House approves bill expanding oversight of medical-marijuana testing laboratories

Harrisburg, March 17 — The Pennsylvania House of Representatives on Tuesday approved House Bill 33, a measure that expands state oversight of medical-marijuana testing laboratories and adds new authority over practitioner certifications, by a vote of 194 to 8.

Representative Frankel, chair of the House Health Committee and the bill’s prime sponsor, told colleagues the legislation is meant to protect patients by ensuring that products meet potency and contaminant standards. “Patients in Pennsylvania shouldn't have to wonder if their medicine is safe,” Frankel said on the floor, adding that the bill gives the Department of Health “the power to oversee lab testing” and requires reporting and monitoring to ensure labels match product contents.

The bill incorporates an amendment from Representative Chvartzik that folded the provisions of House Bill 28 into HB33; Chvartzik said the change gives the Department of Health statutory authority to place conditions on medical-marijuana practitioners in the state registry after news reports showed unusually high certification volumes for some practitioners. “By providing clear statutory authority to the department regarding practitioner certification of patients, which is presently lacking, we can further ensure the health and safety of patients in the medical-marijuana program,” Chvartzik said.

Representative Rapp, the minority chair of the Health Committee, voiced support on the floor and said hearings, testimony and other states’ experiences showed gaps in lab oversight. Frankel and other sponsors cited investigations and studies from other states — including examples from Massachusetts, Connecticut, Colorado and California mentioned on the floor — to argue for stronger state authority now rather than after safety problems emerge.

Clerk records show final passage by a vote of 194 yeas and 8 nays. The clerk indicated the bill will be returned to the Senate with the House’s action noted.

The bill’s provisions extend departmental authority over testing protocols, reporting and product safety standards; proponents said the changes aim to prevent mislabeled potency and contaminated products from reaching patients. The bill also adds explicit statutory authority for the Department of Health to condition practitioner inclusion in the medical-marijuana certification registry.

The House debate lasted through committee remarks and floor presentations before the recorded vote. With final passage in the House, HB33 moves to the Senate for consideration.